Management of urothelial carcinomas of the upper tract: Audit of 2-year follow-up of patients undergoing Nephroureterectomy
BAUS ePoster online library. Ng M. 06/25/19; 265253; CU-10 Disclosure(s): Nothing to disclose
Dr. Michael Ng
Dr. Michael Ng
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Discussion Forum (0)
Rate & Comment (0)
Objectives: To determine how current follow-up strategies following radical nephroureterectomy (for urothelial carcinoma) compare with European guidelines (EAU).

Methods: Retrospective audit of case notes of 31 patients who met eligibility criteria and underwent Nephroureterectomy between 2014-2016 were identified. 2-year Cystoscopic and radiological follow-up data was collected and analysed to determine how follow-up compared to EAU guidelines.

Results: Average time from MDT to first follow-up cystoscopy was 3.8 months. Only 65% (n=15) patients had cystoscopic follow-up within 3 months (as recommended by EAU guidelines). 21.7% of patients had cystoscopic follow-up at 6 months. Patients attended an average of 4 follow-up cystoscopy's over the 2 year period. CTU made up only 25% of surveillance cross-sectional imaging in our hospital.

Conclusions: In our single-centre study, we observed a high degree of variation in cystoscopic follow-up between patients. Average cystoscopic follow-up was 4 cystoscopy's in 24 months (the equivalent of 6 monthly vs EAU recommended 3 monthly). To continue to meet current EAU guidelines changes will therefore need to be made to improve the rate of cystoscopic follow-up. This audit demonstrated follow-up can be improved in our hospital; this could be achieved by introducing standardised follow-up options on operation notes.




Introduction
Upper tract urothelial carcinomas although uncommon, account for upto 10% of urothelial carcinomas1,2. These patients are at particularly high risk of recurrence, with bladder recurrence rates ranging from 22-47%1,3. Close follow-up of these patients is therefore essential due to the risk of recurrence (bladder tumours, local recurrence and metastases). Current EAU guidelines recommend close cystoscopic surveillance and cross-sectional follow-up after radical nephroureterectomy (with cystoscopic follow-up 3 monthly for 2 years and cross-sectional surveillance 6 mont
Objectives: To determine how current follow-up strategies following radical nephroureterectomy (for urothelial carcinoma) compare with European guidelines (EAU).

Methods: Retrospective audit of case notes of 31 patients who met eligibility criteria and underwent Nephroureterectomy between 2014-2016 were identified. 2-year Cystoscopic and radiological follow-up data was collected and analysed to determine how follow-up compared to EAU guidelines.

Results: Average time from MDT to first follow-up cystoscopy was 3.8 months. Only 65% (n=15) patients had cystoscopic follow-up within 3 months (as recommended by EAU guidelines). 21.7% of patients had cystoscopic follow-up at 6 months. Patients attended an average of 4 follow-up cystoscopy's over the 2 year period. CTU made up only 25% of surveillance cross-sectional imaging in our hospital.

Conclusions: In our single-centre study, we observed a high degree of variation in cystoscopic follow-up between patients. Average cystoscopic follow-up was 4 cystoscopy's in 24 months (the equivalent of 6 monthly vs EAU recommended 3 monthly). To continue to meet current EAU guidelines changes will therefore need to be made to improve the rate of cystoscopic follow-up. This audit demonstrated follow-up can be improved in our hospital; this could be achieved by introducing standardised follow-up options on operation notes.




Introduction
Upper tract urothelial carcinomas although uncommon, account for upto 10% of urothelial carcinomas1,2. These patients are at particularly high risk of recurrence, with bladder recurrence rates ranging from 22-47%1,3. Close follow-up of these patients is therefore essential due to the risk of recurrence (bladder tumours, local recurrence and metastases). Current EAU guidelines recommend close cystoscopic surveillance and cross-sectional follow-up after radical nephroureterectomy (with cystoscopic follow-up 3 monthly for 2 years and cross-sectional surveillance 6 mont
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies